← Leaderboards
Seong Sung Shim
Case Western Reserve University
$138,556
Attributed
$138,556
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $0 · FY2015–19$1$1$1$0$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$138,556 · 1
VA$0 · 2
By mechanism
R03$138,556 · 1
I21$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Jianjie Ma$31,916,684
- Martha X Sajatovic$17,916,099
- Jonathan S. Stamler$32,849,627
- Jennifer Beth Levin$4,087,401
- Clark W Distelhorst$12,209,930
Others in their field
Top investigators on “Synapses”
- Michael W Weiner · Northern California Institute Res &Educ$95,051,223
- Jeff W Lichtman · Washington University$52,276,380
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Richard L Huganir · Johns Hopkins University$42,264,873
- Christopher H Van Dyck · Cognition Therapeutics, Inc.$39,259,807
Research focus
SynapsesPharmaceutical PreparationsLithiumS DiseaseTherapeutic EffectAmyloid Beta-ProteinHippocampus (Brain)LearningNeuron LossPropertySynaptic PlasticityTau ProteinsTreatment StrategyVeteransAlzheimer&AposEffective TherapyImpaired CognitionInhibitor/AntagonistMemoryNeurodegenerative DisordersNeuronsAmyloid DepositionAutomobile DrivingAdult
Grant awards (7)
Therapeutic actions of GSK-3 inhibition in rmTBI$0
I21 · FY2019 · VA · contact PI
Therapeutic actions of GSK-3 inhibition in rmTBI$0
I21 · FY2018 · VA · contact PI
Therapeutic actions of GSK-3 inhibition in rmTBI$0
I21 · FY2017 · VA · contact PI
Early Neuronal Signaling Deficits in AD for Novel Therapeutic Development$0
I21 · FY2016 · VA · contact PI
Early Neuronal Signaling Deficits in AD for Novel Therapeutic Development$0
I21 · FY2015 · VA · contact PI
NMDA Antagonist-induced Neurotoxicity in Schizophrenia$75,500
R03 · FY2003 · MH
NMDA Antagonist-induced Neurotoxicity in Schizophrenia$63,056
R03 · FY2002 · MH